Northwest Investment Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PF
APF
Northwest Investment Counselors's XBI Position: Q2 2023 in Review
Northwest Investment Counselors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 350 shares — an estimated $26.7K sold.
Northwest Investment Counselors first reported a position in XBI in Q1 2023 and held it in 1 quarter. The position peaked at $26.7K in Q1 2023. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.
- Northwest Investment Counselors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
- Northwest Investment Counselors sold 350 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $26.7K.
- Northwest Investment Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 1 quarter.
- Northwest Investment Counselors's State Street SPDR S&P Biotech ETF position peaked at $26.7K in Q1 2023.
- 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.
Based on Northwest Investment Counselors's 13F filing for Q2 2023, filed 11 Jul 2023.